food and drug administration

FDA Recalls Blood Pressure Drug

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.

Just The News · 21m

Drug makers recalled blood pressure medicine for having potential cancer-causing chemical, FDA

· 22h · on MSN

Teva recalls 580K blood pressure medication bottles over high carcinogen level

16hon MSN

New deaths and illnesses reported in listeria outbreak tied to recalled pasta meals

Two new deaths and more illnesses have been reported in an outbreak of listeria food poisoning tied to precooked pasta meals ...

Watch live: RFK Jr., FDA chief give remarks on lowering drug prices

Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary ...

A judge to weigh in on SNAP benefits. And, Trump wants to resume nuclear testing

A federal judge is set to decide whether the Trump administration will have to find funds to keep SNAP benefits flowing. And, ...

FDA’s New Fast Drug Review Plan Comes With Trade-Offs for Pharma

The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a ...

1don MSN

Federal health officials push effort to spur cheaper biotech drugs

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

2don MSN

Q&A: What new drug is the FDA reviewing to treat Parkinson’s disease?

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

FDA to Speed Biosimilar Approvals in Push to Cut Drug Costs (1)

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President ...

1don MSN

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

Trump Administration Eases Approval Process for Biosimilar Drugs

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...

Trump’s crackdown on high drug costs: Why India’s pharma industry could emerge as the big winner | Explained

For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...

3don MSN

Paxton sues Tylenol's maker as Trump administration links the drug to autism

Texas Attorney General Ken Paxton alleged Johnson & Johnson deceptively marketed the drug as safe for pregnant Texans.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results